6 Results for "

KLK14

" in MedChemExpress (MCE) Product Catalog:
Products (6)

6 Results for "KLK14" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-P71590
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: KLK14; Kallikrein-Related Peptidase 14 Transcript Variant 2; Kallikrein Related Peptidase 14; Kallikrein-Related Peptidase 14 Transcript Variant 3; KLK-L6; Kallikrein 14; Kallikrein-Like Protein 6; KLKL6; Kallikrein-14; HK14
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-RS07378
Research Areas:  

Others

KLK14 Human Pre-designed siRNA Set A contains three designed siRNAs for KLK14 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS19018
Research Areas:  

Others

Klk14 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Klk14 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS25507
Research Areas:  

Others

Klk14 Rat Pre-designed siRNA Set A contains three designed siRNAs for Klk14 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-150085
CAS No.: 2393881-77-9
Target:  

Kallikrein

Research Areas:  

Inflammation/Immunology

GSK951 is a highly potent, selective, and reversibly covalent KLK5 inhibitor, with an IC50 of approximately 250 pM and a pIC50 of 9.6 against hKLK5. It exhibits over 100-fold selectivity over KLK7, KLK14, matriptase, and elastase. GSK951 binds to the catalytic site of KLK5 via covalent interaction with the catalytic serine, with a slow dissociation rate. GSK951 improves skin barrier function, reduces transepidermal water loss, decreases the expression of proinflammatory cytokines, and inhibits the elevated KLK5 protease activity in the stratum corneum. GSK951 can be used in studies related to skin barrier dysfunction.
loading...
    loading...
Cat. No.: HY-P11840
KLK5-IN-1 is a selective kallikrein 5 (KLK5) inhibitor with an IC50 of 14 nM and a Ki of 11 nM. KLK5-IN-1 reduces KLK5-mediated PAR2-dependent calcium mobilization. KLK5-IN-1 improves epithelial barrier integrity. KLK5-IN-1 can be used in research related to atopic dermatitis and Netherton syndrome .
loading...
    loading...